NRX Pharmaceuticals
NRXP
NRXP
37 hedge funds and large institutions have $2.18M invested in NRX Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.99% less ownership
Funds ownership: 1.54% → 0.55% (-0.99%)
91% less capital invested
Capital invested by funds: $25.1M → $2.18M (-$23M)
Holders
37
Holding in Top 10
–
Calls
$237K
Puts
$67K
Top Buyers
1 | +$178K | |
2 | +$92K | |
3 | +$83.6K | |
4 |
BlackRock
New York
|
+$76K |
5 |
Citadel Advisors
Miami,
Florida
|
+$55K |
Top Sellers
1 | -$15.3M | |
2 | -$1.53M | |
3 | -$349K | |
4 |
Renaissance Technologies
New York
|
-$64.5K |
5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$50K |